Promotion: Investments in small cap shares involves a high degree of risk and are not suitable for all investors. Companies listed on the AIM or Aquis market can be highly volatile and are considered high-risk speculative investments.
THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN MEDPAL PLC IN ANY JURISDICTION IN WHICH ANY SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL.
MedPal AI plc (AIM: MPAL), a UK-based digital health and artificial intelligence ("AI") company focused on wellness management, announces a strategic partnership with Independent Gyms Ltd ("Independent Gyms"), giving members of over 2,000 independent gyms free access to the MedPal AI app on iOS and Android. The app collates data from multiple wearable fitness devices, which is analysed by AI to produce personalised programmes including workout, nutrition, and recovery plans. Provision of the app to Independent Gyms will help associated gyms compete with larger chains and add value for members.
Through this partnership, Independent Gyms' members in the UK and Ireland will gain free access to the MedPal AI app, enabling gym owners to offer enhanced value to their communities. This initiative not only supports independent operators in competing with larger chains but also promotes a more inclusive, tech-enabled fitness landscape that prioritises user engagement and long-term health outcomes.
After a free 12-month access period, Independent Gyms' members who wish to continue using the app will be required to subscribe. Subscription prices will start at £2.99 a month. Independent Gyms shall be entitled to receive 25 per cent. commission (net of platform fees) on subscriptions from its members following the end of the free access period. MedPal AI will also exhibit at the Independent Gym Show in November 2025.
The partnership comes amid strong sector growth: UK gym memberships currently generate nearly £6 billion per annum1, with membership penetration at 15.1%1, and the fitness wearables market is expected to reach £1.3 billion in 2025, expanding at a 16.7% CAGR through to 20302.
Jason Drummond, Chief Executive Officer of MedPal AI, said:
"The partnership with Independent Gyms will bring our AI health app to thousands of users, supporting MedPal's early-mover positioning in the fast-growing UK fitness and wearables market. The collaboration aims to make advanced AI wellness tools accessible, helping independent gyms improve members' experiences and boost client retention."
Rob Handy, Founder of Independent Gyms, added:
"This partnership with MedPal AI is a game-changer for our network of over 2,000 independent facilities. By integrating their app, we are empowering our members to embrace the digital revolution in fitness, aligning perfectly with the growing demand for wearable, integrated, data-driven health solutions in the UK."
1UK Active launches UK Health and Fitness Market report with analysis by Deloitte
2UK Fitness Tracker Market Size & Outlook, 2030
About MedPal AI
MedPal AI is a UK-based digital health company specialising in AI-driven wellness management. Its core app aggregates data from over 100 wearables and health apps (e.g. Apple Health, Fitbit, Garmin) into a unified profile, offering non-clinical, personalised lifestyle guidance through its AI wellness coach. The Company is also developing conversational AI to provide voice-based, real-time health insights, alerts, and recommendations.
MedPal AI also has a partnership agreement with Epassi UK Limited ("Epassi"), which will grant exclusive, zero-cost access to the MedPal AI app for a limited time across Epassi's network of 11m+ employees at major firms that include Siemens and Volvo. Beyond consumers, MedPal AI plans to expand via B2B licensing to healthcare providers, businesses, and insurers, with potential use in insurance-linked wellness programs to reduce premiums and drive new revenue through institutional partnerships.
About Independent Gyms
Independent Gyms is a membership platform, founded in 2018, which supports independent fitness facilities across the UK and Ireland through securing competitive offers for its members from more than 100 partners; providing resources to support their business, such as financial planning templates and contracts and creating and sharing insights on independent facilities and customers.
Independent Gyms also provides informative and engaging workshops, events and webinars and drives its Facebook community to help gym owners share knowledge and experience, while also using its social platforms to champion independent facilities.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018). The Directors of the Company take responsibility for the contents of this announcement.
MedPal AI plc
Jason Drummond, Chief Executive Officer
via Square1 Consulting
Cairn Financial Advisers LLP
Louise O'Driscoll/Jo Turner
+44 20 7213 0880
Clear Capital Markets Limited
+44 20 3869 6080
Bob Roberts/ Nick Josh
Square1 Consulting
David Bick
+44 7831 381201
Forward Looking Statements
This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the timing and granting of regulatory and other third party consents and approvals, uncertainties regarding the Company's or any third party's ability to execute and implement future plans, and the occurrence of unexpected events.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
.png)
Fill out the short form below to get instant access to this free report revealing our Top 10 stock picks for September.
Nothing in the above article should be considered investment advice.
Small Cap or Aquis listed companies can be highly illiquid making them difficult to sell at the quoted price, and in some cases, it may be difficult to sell them at any price. Small Cap or Aquis listed companies can have a large bid / offer spread which means there could be a large difference between the buying and selling price. Companies listed on the Aquis market can be highly volatile and are considered high risk speculative investments. The value of your investment can go down as well as up, your Capital is at risk you may not get back the amount invested. Please ensure that you fully understand the risks involved. If in any doubt, please seek independent financial advice. This document is published by Clear Capital Markets and does not constitute a solicitation or personal recommendation for the purchase or sale of investment. The investments referred to may not be suitable for all investors. Any data or views given should not be construed as investment advice. Every effort is made to ensure the accuracy of the information, but no assurance or warranties are given.
Clear Capital Markets Corporate Broking acts as a Corporate Broker to MedPal PLC and holds warrants and shares in the company. Employees and/or directors of Clear Capital Markets may deal in shares of MedPal PLC for their own personal accounts. These scenarios may give rise to a conflict of interest where Clear Capital Markets also provides clients with an advisory service for transactions involving MedPal PLC. The firm has established Conflicts of Interest (“COI”) and Personal Account Dealing (“PAD”) policies to mitigate the risk of a conflict causing damage to the interests of its clients. The measures taken include (i) enforcing minimum holding or ‘lock-in’ periods; and (ii) requiring internal review and approval from the compliance department for employees or directors entering into personal transactions involving MedPal PLC. The COI and PAD policies are available upon request. Before Clear Capital Markets proceeds with a placing, a number of factors are considered including: liquidity of stock, company diversification, market capitalisation and potential news flow. Only once minimum criteria are satisfied would we elect to proceed. Any remuneration payable to Clear Capital Markets has no bearing on whether it proceeds with a placing. These administrative controls mitigate the risk of a conflict causing damage to the interest of a client, but the inherent risks of this business model cannot be eliminated. Accordingly, Clear Capital Markets is required to disclose this conflict to help clients to assess the service that they are being offered in light of Clear Capital’s own interests, and to decide on the extent (if at all) to which they will rely on, or proceed with, the service.
We will reach out for a quick introductory fact find to see how we can best serve your specific needs and arrange a convenient time for a consultation with a member of the appropriate specialist team.
An Advisory Broker will contact you for a deeper fact find and share information on how we can best enhance your portfolio.
We will conduct a full RCP in accordance with FCA regulations to ensure that your appropriate risk profile is set. You will then have access to an extensive suite of investments, supported by your dedicated Advisory Broker.
